
Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug
By Jonathan Stempel NEW YORK (Reuters) -Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic versions of its blockbuster blood cancer drug Pomalyst off the market so it could retain a …